Tahoe Therapeutics
Tahoe Therapeutics

Tahoe Therapeutics

Developing novel therapies for neurological disorders.

Website
ActiveSan Mateo, United States

About

Tahoe Therapeutics is a biotechnology company focused on developing innovative treatments for debilitating neurological diseases. Their research aims to address unmet medical needs in conditions such as Alzheimer's disease, Parkinson's disease, and ALS.

Key facts

Website
tahoetherapeutics.com
Headquarters
San Mateo, United States
Total funding
$30M (Series A)
Valuation
Private
Business model
B2B
Tags
Biotech
MedTech
HealthTech
Drug Discovery
Clinical Trials

Funding rounds

Funding rounds raised by Tahoe Therapeutics
DateRoundAmountLead investors
27 Feb 2025Series A$30MPolaris Partners, Deerfield Management
Scores
Measured, not editorial
Agent Readiness
50/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Scan this site yourselfHow to improve
Site Speed
51/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Open in PageSpeed Insights
Add first review

Frequently asked

How much funding has Tahoe Therapeutics raised?

Tahoe Therapeutics has raised a total of $30M in funding. The most recent round on record is Series A.